{"cluster": 60, "subcluster": 23, "abstract_summ": "Accumulating evidence has reported that aberrant RNAs promote carcinogenesis in many cancers, including liver cancer, leukemia, melanoma, lung cancer, breast cancer, and other cancers, in which abnormal RNA processing occurs in normal cells.Recently, with the development of RNA sequencing technologies such as next-generation sequencing (NGS) for RNA, numerous variations of alternatively processed RNAs made by alternative splicing, RNA editing, alternative maturation of microRNA (miRNA), RNA methylation, and alternative polyadenylation have been uncovered.Especially in cancer development, aberrant RNAs caused by deregulated RNA modifiers or regulators are related to progression.Indeed, in addition to an extensive regulatory scheme implemented at the level of transcription, the complexity of transcript processing following transcription is dramatically increased.By conducting parallel global profiling experiments with larp1 mutants, we discovered that the TOR-LARP1 signaling axis controls 5\u2032TOP mRNA translation in plants and defined a set of conserved eukaryotic 5\u2032TOP mRNAs that encode cyclins, importins/karyopherins, translation elongation factors, and TCTP1, among others.", "title_summ": "Parallel global profiling of plant TOR dynamics reveals a conserved role for LARP1 in protein translationAn Insulin-Sensitive Circular RNA that Regulates Lifespan in DrosophilaA Guide to the Short, Long and Circular RNAs in Hypertension and Cardiovascular DiseasemRNA Metabolism in Cardiac Development and Disease: Life After TranscriptionInitiation Factor 3 is Dispensable For Mitochondrial Translation in Cultured Human Cells.Pathogenic diversity of RNA variants and RNA variation-associated factors in cancer development.", "title_abstract_phrases": "Accumulating evidence has reported that aberrant RNAs promote carcinogenesis in many cancers, including liver cancer, leukemia, melanoma, lung cancer, breast cancer, and other cancers, in which abnormal RNA processing occurs in normal cells.Recently, with the development of RNA sequencing technologies such as next-generation sequencing (NGS) for RNA, numerous variations of alternatively processed RNAs made by alternative splicing, RNA editing, alternative maturation of microRNA (miRNA), RNA methylation, and alternative polyadenylation have been uncovered.Especially in cancer development, aberrant RNAs caused by deregulated RNA modifiers or regulators are related to progression.Indeed, in addition to an extensive regulatory scheme implemented at the level of transcription, the complexity of transcript processing following transcription is dramatically increased.In this review, the underlying mechanisms of variations in the RNA life cycle and the biological impacts of RNA variations on carcinogenesis will be discussed, and therapeutic strategies for the treatment of tumor malignancies will be provided."}